Suprasma inhalation vapour

Dexa Medica

Ingredients in every 2.5 ml

Salbutamol 2.5 mg

Each package contains

10 ampoules of 2.5 ml

Other details

Dosage form:Inhalation vapour; solution
Flavour None

W.H.O. classification

ATC Level 1 R - Respiratory system
ATC Level 2 R03 - Drugs for Obstructive Airway Diseases
ATC Level 3 R03A - Adrenergics; Inhalants

Warnings

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution and after consultation with your doctor.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Available in

Indonesia

Dosage information

18 YEARS OLD AND ABOVE
A suitable starting dose of salbutamol by wet inhalation is 2.5 mg, administered 3-4 times daily by nebulization.
However, in domiciliary practice, the benefits of increasing the dose of nebulized salbutamol should be weighed against the risk that a deterioration in the patient’s underlying conditions may be masked. In such circumstances, a medical assessment should be considered since alternative therapy may be indicated. Treatment may be repeated four times daily. Salbutamol solution for inhalation is intended to be used undiluted. However, if prolonged delivery time is desirable (more than 10 minutes) dilution using sterile normal saline for injection as a diluent may be required.

Salbutamol solution for inhalation is to be used with a nebulizer, under the direction of a physician. The solution must not be injected.

1.5 TO 18 YEARS OLD
A suitable starting dose of salbutamol by wet inhalation is 2.5 mg, administered 3-4 times daily by nebulization.
However, in domiciliary practice, the benefits of increasing the dose of nebulized salbutamol should be weighed against the risk that a deterioration in the patient’s underlying conditions may be masked. In such circumstances, a medical assessment should be considered since alternative therapy may be indicated. Treatment may be repeated four times daily. Salbutamol solution for inhalation is intended to be used undiluted. However, if prolonged delivery time is desirable (more than 10 minutes) dilution using sterile normal saline for injection as a diluent may be required.

Salbutamol solution for inhalation is to be used with a nebulizer, under the direction of a physician. The solution must not be injected.

0 TO 1.5 YEARS OLD
Clinical efficacy of nebulized salbutamol in infants under 18 months is uncertain. As transient hypoxemia may occur, supplemental oxygen therapy should be considered.

Indication

– Routine management of chronic bronchospasm-unresponsive to conventional therapy.
– Treatment of acute attack of bronchospasm (status asthmaticus).